These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30332475)

  • 1. Nanotracing and cavity-ring down spectroscopy: A new ultrasensitive approach in large molecule drug disposition studies.
    Kratochwil NA; Dueker SR; Muri D; Senn C; Yoon H; Yu BY; Lee GH; Dong F; Otteneder MB
    PLoS One; 2018; 13(10):e0205435. PubMed ID: 30332475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human ADME for YH12852 using wavelength scanning cavity ring-down spectroscopy (WS-CRDS) after a low radioactivity dose.
    Kim A; Dueker SR; Dong F; Roffel AF; Lee SW; Lee H
    Bioanalysis; 2020 Jan; 12(2):87-98. PubMed ID: 31928227
    [No Abstract]   [Full Text] [Related]  

  • 3. Attomole detection of 3H in biological samples using accelerator mass spectrometry: application in low-dose, dual-isotope tracer studies in conjunction with 14C accelerator mass spectrometry.
    Dingley KH; Roberts ML; Velsko CA; Turteltaub KW
    Chem Res Toxicol; 1998 Oct; 11(10):1217-22. PubMed ID: 9778319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laser-based radiocarbon detection in the laboratory: How soon?
    Murnick DE
    J Labelled Comp Radiopharm; 2019 Sep; 62(11):768-775. PubMed ID: 31369168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerator mass spectrometry in pharmaceutical research and development--a new ultrasensitive analytical method for isotope measurement.
    Garner RC
    Curr Drug Metab; 2000 Sep; 1(2):205-13. PubMed ID: 11465084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomedical accelerator mass spectrometry: recent applications in metabolism and pharmacokinetics.
    Lappin G; Stevens L
    Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1021-33. PubMed ID: 18680438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A validation study comparing accelerator MS and liquid scintillation counting for analysis of 14C-labelled drugs in plasma, urine and faecal extracts.
    Garner RC; Barker J; Flavell C; Garner JV; Whattam M; Young GC; Cussans N; Jezequel S; Leong D
    J Pharm Biomed Anal; 2000 Dec; 24(2):197-209. PubMed ID: 11130199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of mass balance, pharmacokinetics and disposition of [14C(U)]- and [125I]recombinant human interleukin-2 in cynomolgus monkeys.
    Nadeau RW; Satoh H; Scheide S; Crowl R; Conroy R; Garland WA; Liberato DJ
    Drug Metab Dispos; 1995 Sep; 23(9):904-9. PubMed ID: 8565779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurements of Carbon-14 With Cavity Ring-Down Spectroscopy.
    McCartt AD; Ognibene T; Bench G; Turteltaub K
    Nucl Instrum Methods Phys Res B; 2015 Oct; 361():277-280. PubMed ID: 27065506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying Carbon-14 for Biology Using Cavity Ring-Down Spectroscopy.
    McCartt AD; Ognibene TJ; Bench G; Turteltaub KW
    Anal Chem; 2016 Sep; 88(17):8714-9. PubMed ID: 27458740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical performance of accelerator mass spectrometry and liquid scintillation counting for detection of 14C-labeled atrazine metabolites in human urine.
    Gilman SD; Gee SJ; Hammock BD; Vogel JS; Haack K; Buchholz BA; Freeman SP; Wester RC; Hui X; Maibach HI
    Anal Chem; 1998 Aug; 70(16):3463-9. PubMed ID: 9726169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic analysis of 14C-ursodiol in newborn infants using accelerator mass spectrometry.
    Gordi T; Baillie R; Vuong le T; Abidi S; Dueker S; Vasquez H; Pegis P; Hopper AO; Power GG; Blood AB
    J Clin Pharmacol; 2014 Sep; 54(9):1031-7. PubMed ID: 24805288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracavity optogalvanic spectroscopy. An analytical technique for 14C analysis with subattomole sensitivity.
    Murnick DE; Dogru O; Ilkmen E
    Anal Chem; 2008 Jul; 80(13):4820-4. PubMed ID: 18533685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of drug conjugation on pharmacokinetics and tissue distribution of anti-STEAP1 antibody-drug conjugates in rats.
    Boswell CA; Mundo EE; Zhang C; Bumbaca D; Valle NR; Kozak KR; Fourie A; Chuh J; Koppada N; Saad O; Gill H; Shen BQ; Rubinfeld B; Tibbitts J; Kaur S; Theil FP; Fielder PJ; Khawli LA; Lin K
    Bioconjug Chem; 2011 Oct; 22(10):1994-2004. PubMed ID: 21913715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic erythrocyte labeling and attomole pharmacokinetic tracing of 14C-labeled folic acid with accelerator mass spectrometry.
    Buchholz BA; Arjomand A; Dueker SR; Schneider PD; Clifford AJ; Vogel JS
    Anal Biochem; 1999 May; 269(2):348-52. PubMed ID: 10222009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies.
    Glassman PM; Balthasar JP
    J Pharmacokinet Pharmacodyn; 2016 Aug; 43(4):427-46. PubMed ID: 27377311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel use of accelerator mass spectrometry for the quantification of low levels of systemic therapeutic recombinant protein.
    Lappin G; Garner RC; Meyers T; Powell J; Varley P
    J Pharm Biomed Anal; 2006 Jun; 41(4):1299-302. PubMed ID: 16554138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the tissue distribution and excretion by accelerator mass spectrometry of the nonadecapeptide 14C-Moli1901 in beagle dogs after intratracheal instillation.
    Rickert DE; Dingley K; Ubick E; Dix KJ; Molina L
    Chem Biol Interact; 2005 Jun; 155(1-2):55-61. PubMed ID: 15893299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomedical applications of accelerator mass spectrometry-isotope measurements at the level of the atom.
    Barker J; Garner RC
    Rapid Commun Mass Spectrom; 1999; 13(4):285-93. PubMed ID: 10097404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applications of accelerator mass spectrometry for pharmacological and toxicological research.
    Brown K; Tompkins EM; White IN
    Mass Spectrom Rev; 2006; 25(1):127-45. PubMed ID: 16059873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.